|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18,660.00 ARS | +1.36% |
|
+9.96% | +11.94% |
| 06-29 | Medical journal retracts paper on Amgen's Tavneos drug trial after FDA findings | RE |
| 06-26 | US FDA greenlights Viridian's thyroid eye disease drug | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.81% | +11.60% | +11.31% | +40.04% | +14.45% | +58.61% | +164.79% | +436.22% | +1,473.81% | 1,077B | |
| +1.51% | +11.77% | +14.73% | +7.51% | +24.91% | +69.61% | +57.53% | +57.60% | +116.63% | 613B | |
| +0.38% | +10.56% | +16.81% | +21.45% | +11.30% | +39.49% | +90.88% | +126.46% | +311.44% | 448B | |
| +0.99% | +5.24% | +1.82% | +7.30% | +2.16% | +28.17% | +22.73% | -3.87% | +31.90% | 332B | |
| -0.14% | +8.04% | +4.09% | -0.03% | +3.68% | +39.85% | +27.27% | +64.99% | +234.57% | 293B | |
| -0.06% | +4.92% | +7.11% | +5.93% | +15.15% | +31.21% | +41.59% | +49.23% | +58.24% | 286B | |
| -0.96% | +4.98% | +7.49% | +37.81% | -3.18% | -28.02% | -40.96% | +20.70% | +77.36% | 215B | |
| -1.21% | +1.17% | -6.03% | -5.90% | +2.92% | +14.15% | +66.20% | +85.97% | +53.56% | 159B | |
| +0.33% | -2.83% | -6.91% | -9.87% | -2.13% | +0.74% | -32.53% | -37.67% | -30.39% | 138B | |
| +1.69% | +7.04% | +11.64% | +15.37% | +10.21% | +13.22% | +43.50% | +153.91% | +487.82% | 125B | |
| +1.81% | +7.06% | +2.41% | +0.03% | +8.57% | +26.34% | -8.50% | -11.63% | -19.78% | 117B | |
| -0.18% | +2.80% | +3.21% | -3.39% | +8.50% | +40.84% | +41.15% | +11.43% | +4.60% | 104B | |
| +0.57% | +4.15% | +0.28% | -7.92% | -8.73% | -8.47% | -22.79% | -14.53% | +1.62% | 103B | |
| -0.53% | +0.24% | -4.46% | -12.93% | -8.53% | +0.20% | +81.51% | +75.35% | +526.59% | 75.68B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| -2.06% | +20.56% | +26.01% | +20.31% | +24.37% | +70.64% | -8.87% | -10.85% | -48.34% | 52.66B | |
| -0.81% | +3.26% | +0.37% | -10.08% | +6.25% | +16.09% | +12.75% | +38.76% | +15.70% | 49.71B | |
| +8.75% | +9.31% | +10.27% | -4.08% | -11.15% | +1.89% | +14.57% | -22.84% | +251.87% | 47.27B | |
| +0.03% | +4.31% | +1.99% | -5.04% | -7.04% | -7.90% | +9.11% | - | - | 40.58B | |
| Average | +0.55% | +6.21% | +5.67% | +5.36% | +5.09% | +22.59% | +31.11% | +59.95% | +208.66% | 228.42B | |
| Weighted average by Cap. | +0.68% | +8.35% | +8.41% | +15.72% | +10.27% | +37.94% | +68.26% | +148.76% | +478.03% |
- Stock Market
- Stocks
- AMGN Stock
- AMGN Stock
- Sector Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
